Clinical Trial Update: Study to Learn More About the Potential of Antifungal Cream V61-044 Containing Trolamine to Cause Irritant Reaction of the Skin to Ultra Violet Light in Healthy Human Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether antifungal cream V61-044 with trolamine causes irritant skin reactions under UV light in healthy subjects; study completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatitis
• Phototoxic Dermatitis

Drugs mentioned

• V61-044

Snippet

Sponsor: Bayer | Conditions: Dermatitis, Phototoxic | Phase 3 | Status: COMPLETED | Results posted: 2020-09-21